Erenumabix (Erenvex)

Product detail for Erenumabix, INN: erenumabix. Therapeutic area: Neurology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.

Product ID
PROD-020
INN
erenumabix
Therapeutic Area
Neurology
Status
In Progress
Owner
Sarah Chen
Created
2022-10-05
Last Updated
2023-05-07
Markets
10
Presentations
FormStrengthRoute
Hard capsule100 mg/mLTransdermal
Concentrate for solution for infusion5 mg/mLTransdermal
Soft capsule5 mgInhalation
Active Substances
IDNameINNCASTypeStatus
SUB-004Neprilozoneneprilozone85846-29-9biologicActive
SUB-046Cyclodextrincyclodextrin85528-98-1small-moleculePending
Applications (3)
Application #MarketProcedure TypeStatusOwnerSubmitted
MOH-IL-2020-0020ArgentinaNDABlockedAisha Okonkwo2023-05-08
MFDS-2020-0050ArgentinasMAAOverdueCarlos Mendez2022-05-07
MOH-IL-2020-0080ArgentinasMAAOverdueDmitri Volkov2023-03-28
Markets (10)
EU — European UnionFR — FranceIT — ItalyNL — NetherlandsKR — South KoreaTW — TaiwanSG — SingaporeAR — ArgentinaTR — TurkeyPL — Poland
Labeling Artefacts
IDTypeMarketVersionLanguageStatus
LBL-020SmPCArgentina14.8nlApproved
LBL-050SmPCArgentina16.8nlActive
LBL-080SmPCArgentina17.3frApproved
LBL-110LabelingArgentina11.9nlIn Progress
LBL-140LabelingArgentina9.2svSubmitted